AZN three-lens brief
Evidence-based stock research on AZN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 15.2pp over 30 days.
- Outperforming SPY by 15.2pp over 30 days.
- Reported earnings on 2026-10-30.
AZN closed at $185.48 (-0.69%) as of 2026-11-12. Market cap: $287.66B. P/E (trailing) 26.2. Price is above the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 15.2pp over 30 days.. Last quarter: Revenue $16.21B, net income $3.12B, free cash flow $5.63B.
Why three lenses on AZN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AZN across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AZN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AZN brief"></iframe>